Clinical Edge Journal Scan

Obesity Associated With Disease Severity in Moderate to Severe Atopic Dermatitis


 

Key clinical point: Obesity is significantly associated with patient- and physician-assessed measures of atopic dermatitis (AD) disease severity.

Major finding: Increased body mass index (BMI) values were associated with higher disease severity as assessed by objective Scoring AD (adjusted β 1.24; P = .013) and patient-oriented eczema measure (adjusted β 1.09; P = .038) scores.

Study details: This study based on data from the prospective observational TREATgermany registry included 1416 patients with moderate to severe AD who were either underweight (BMI < 18.5 kg/m 2; n = 33), normal weight or overweight (nonobese; BMI ≥ 18.5 and < 30 kg/m 2; n = 1149), or obese (BMI ≥ 30 kg/m 2; n = 234).

Disclosures: The TREATgermany registry is supported by AbbVie Deutschland GmbH & Co. KG, Galderma SA, LEO Pharma GmbH, Lilly Deutschland GmbH, Pfizer Inc., and Sanofi. Eight authors declared serving as consultants or lecturers for or receiving research grants, personal fees, or lecture or consulting honoraria from various sources, including some of the supporters of TREATgermany.

Source: Traidl S, Hollstein MM, Kroeger N, et al, and The TREATgermany Study Group. Obesity is linked to disease severity in moderate to severe atopic dermatitis—Data from the prospective observational TREATgermany registry. J Eur Acad Dermatol Venereol. 2024 (Apr 25). doi: 10.1111/jdv.20042 Source

Recommended Reading

No Improvement in Atopic Dermatitis Severity Upon Vitamin D Supplementation
MDedge Dermatology
Passive Smoking May Increase the Risk for Atopic Dermatitis in Offspring
MDedge Dermatology
Atopic Dermatitis Increases the Risk for Lymphoma
MDedge Dermatology
Real-World Study Confirms Efficacy of Baricitinib in Atopic Dermatitis
MDedge Dermatology
Filaggrin Loss-of-Function Variants Associated With Atopic Dermatitis Outcomes
MDedge Dermatology
Dupilumab Treatment for Atopic Dermatitis Increases Risk for Cutaneous T-Cell Lymphoma
MDedge Dermatology
Upadacitinib Improved Patient-Reported Outcomes in Atopic Dermatitis
MDedge Dermatology
ADHD Behavioral Patterns Linked to Prurigo Nodularis Development in Children With Atopic Dermatitis
MDedge Dermatology
Commentary: Studies Often Do Not Answer Clinical Questions in AD, May 2024
MDedge Dermatology
Antibiotics in Early Infancy Disrupt Gut Microbiome and Increase Risk for Atopic Dermatitis
MDedge Dermatology